DANVERS, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Medwave Inc. (Nasdaq: MDWV - News), the innovator in sensor-based, non-invasive blood pressure measuring solutions, announced today that it has received clearance by the U.S. Food and Drug Administration (FDA) to market Fusion(TM), the first completely sensor-based blood pressure with vital signs options monitor.
